ストックスクリーナーアプリを入手
0.3765
3.95%
-0.0155
アフターアワーズ：
.37
-0.0065
-1.73%
Immunoprecise Antibodies Ltd (IPA) 最新ニュース
ImmunoPrecise Antibodies Earnings Call Highlights Growth - TipRanks
Immunoprecise stock target cut to $5 by H.C. Wainwright - Investing.com Australia
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates - MSN
ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo Finance
ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024) - Yahoo Finance
ImmunoPrecise Antibodies Reports Q3 FY25 Financial Results - TipRanks
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 - 01Net
Immunoprecise Antibodies Ltd reports results for the quarter ended January 31Earnings Summary - TradingView
Immunoprecise Antibodies (IPA) Reports Financial Results And Recent Business Highlights For Third Quarter Fiscal Year 2025 - MarketScreener
IMMUNOPRECISE ANTIBODIES Earnings Results: $IPA Reports Quarterly Earnings - Nasdaq
A Look Ahead: ImmunoPrecise Antibodies's Earnings Forecast - Benzinga
IMMUNOPRECISE ANTIBODIES Earnings Preview: Recent $IPA Insider Trading, Hedge Fund Activity, and More - Nasdaq
Immunoprecise Antibodies Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView
ImmunoPrecise Antibodies (IPA) to Release Quarterly Earnings on Friday - Defense World
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - MSN
ImmunoPrecise Antibodies’ (IPA) Buy Rating Reiterated at HC Wainwright - Defense World
ImmunoPrecise partners for cancer drug advancement By Investing.com - Investing.com Australia
What's Going On With ImmunoPrecise Stock Thursday? - Benzinga
ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics. - 01Net
Sector Update: Health Care -March 13, 2025 at 08:52 am EDT - Marketscreener.com
ImmunoPrecise Antibodies Signs Partnership Deal to Develop Cancer Treatments -March 13, 2025 at 07:55 am EDT - Marketscreener.com
ImmunoPrecise Antibodies Partners for $10M Cancer Therapeutics Development - TipRanks
Positive Signs As Multiple Insiders Buy ImmunoPrecise Antibodies Stock - Yahoo Finance
ImmunoPrecise partners for cancer drug advancement - Investing.com
IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025 - 01Net
ImmunoPrecise Q3 Earnings Postponed: Auditors Request Extra Time for Goodwill Review - StockTitan
ImmunoPrecise Antibodies Reschedules Q3 Financial Results Release - TipRanks
ImmunoPrecise Antibodies (IPA) to Release Earnings on Thursday - Defense World
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest Update - Defense World
ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery - ACCESS Newswire
ImmunoPrecise Antibodies to Announce Q3 Fiscal 2025 Results - TipRanks
AI Antibody Pioneer ImmunoPrecise Sets March 13 Earnings CallWhat's Next for This Biotech Innovator? - StockTitan
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025 - Yahoo Finance
ImmunoPrecise Antibodies Ltd. (IPA) Expands AI Leadership with Dr. Kamil Isaev Appointment - Insider Monkey
IPA and Ribopro form mRNA antibody discovery collaboration - Yahoo Finance
ImmunoPrecise Antibodies appoints Joseph Scheffler interim CFO - MSN
IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy - 01Net
ImmunoPrecise & RIBOPRO Partner for AI-Powered Antibody Discovery - Contract Pharma
ImmunoPrecise Antibodies and RIBOPRO Partner to Revolutionize Antibody Discovery - TipRanks
ImmunoPrecise Antibodies annonce un remaniement de son équipe de direction - The Hastings Tribune
ImmunoPrecise Antibodies Announces Key Leadership Changes - Voice Of Alexandria
AI Pioneer Joins ImmunoPrecise Board: Can New Leadership Accelerate Biotech Innovation? - Stock Titan
ImmunoPrecise Antibodies Transfers to Nasdaq Capital Market, Gains Extension - TipRanks
Immunoprecise Antibodies Announces Transfer To Nasdaq Capital Market And Extension Of Bid Price Compliance Period - Marketscreener.com
ImmunoPrecise Antibodies Announces Transfer to Nasdaq Capital Market and Extension of Bid Price Compliance Period - Business Wire
ImmunoPrecise Antibodies Ltd (IPA) Shares Up Despite Recent Market Volatility - The News Heater
Check Out ImmunoPrecise Antibodies Ltd (IPA)’s Trade Data Rather Than the Analysts’ Views - SETE News
ImmunoPrecise Antibodies Ltd (IPA) presents a great opportunity, but the stock is slightly overvalued - US Post News
ImmunoPrecise Antibodies Boosts Financial Position Through Successful Capital Initiatives - TipRanks
ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Down 3.9% – Here’s Why - Defense World
ImmunoPrecise Antibodies Ltd. (IPA) Unveils AI-Developed GLP-1 Therapies for Type 2 Diabetes and Obesity, Pioneering New Frontiers in Biotech Innovation - Insider Monkey
1.05%
1.79%
大文字化:
|
ボリューム (24 時間):